Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing therapies for autoimmune diseases with significant unmet medical needs. The company has introduced LUPKYNIS® (voclosporin), the first FDA-approved oral treatment for adult lupus nephritis, and is advancing AUR200, a dual inhibitor targeting BAFF and APRIL for broader autoimmune disease treatments. Aurinia's focus on innovative drug development positions it as a leader in addressing complex immunological conditions.
The Immunology Sales Specialist is responsible for calling on practicing physicians, hospitals, clinics, and other health-related organizations within the assigned territory. The Immunology Specialist must provide current information about assigned products and their approved indications to healthcare professionals.
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing therapies for autoimmune diseases with significant unmet medical needs. The company has introduced LUPKYNIS® (voclosporin), the first FDA-approved oral treatment for adult lupus nephritis, and is advancing AUR200, a dual inhibitor targeting BAFF and APRIL for broader autoimmune disease treatments. Aurinia's focus on innovative drug development positions it as a leader in addressing complex immunological conditions.
Aurinia Pharmaceuticals Inc.